Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People admitted to an intensive care unit (ICU) due to a sudden, serious brain injury
- People whose brain injury has been confirmed by a CT scan and/or MRI scan
- People for whom a contrast ultrasound scan (a special type of imaging using a contrast agent to improve the pictures) is needed as part of their care
- Consent has been given by the patient or a family member/relative on their behalf
Who may not be able to join:
- People who are pregnant
- People whose skull does not allow a clear enough window for the ultrasound to work properly (confirm with trial site)
- People with certain serious heart or lung conditions, including: a recent heart attack or acute coronary syndrome, severe heart disease requiring surgery to restore blood flow, high blood pressure in the lungs above a certain level, a specific type of abnormal connection between the right and left sides of the heart, a severe lung condition called ARDS, or people currently being treated with a medication called dobutamine
- People with a known allergy or previous bad reaction to the contrast agent used in this trial (called SonoVue®)
- People receiving State Medical Assistance (a form of government-funded healthcare support) (confirm with trial site regarding local equivalent)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Romain BARTHELEMY, MD, AP-HP Lariboisière Hospital, Department of Anaesthesia and Intensive Care
Phone: +33 (0)1 49 95 85 15
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluation of the heterogeneity of brain perfusion by time-to-peak (TPI) measurement; Evaluation of the heterogeneity of brain perfusion by peak-intensities (PI) measurement
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.